UPDATE : Friday, September 21, 2018
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon  |  2018-09-10 16:25
Doctors call for tighter quarantine control over MERS case
Korea’s medical community urged the government to prepare measures to fix t...
by Choi Gwang-seok  |  2018-09-10 15:40
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun  |  2018-09-10 14:59
Major hospitals successfully contain Korea’s 1st MERS case in 3 years
The so-called big-five hospitals have successfully managed to contain the M...
by Lee Han-soo  |  2018-09-10 14:25
Kwangdong licenses Canadian company’s nonsteroidal anti-inflammatory drug candidate
Kwangdong Pharmaceutical said Monday that it has signed a licensing agreeme...
by Lee Han-soo  |  2018-09-10 14:23
MERS fear haunts Korea again
The Korean health authorities have confirmed the first case of Middle East ...
by Kwak Sung-sun  |  2018-09-10 14:12
Seoul forced to toughen rules to end ‘healthcare dine and dash' by expats
In May 2015, a Mongolian came to Korea and gained access to health insuranc...
by Lee Han-soo  |  2018-09-07 18:17
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control
The government has ordered Pfizer Korea to halt imports of three drugs for ...
by Lee Hye-seon  |  2018-09-07 16:24
‘AI will not solve all the problems in the medical sector’
The Korean medical community is seeking to combine artificial intelligence ...
by Lee Han-soo  |  2018-09-07 16:23
Is inter-Korean health community feasible?
A South Korean medical expert claimed that two Koreas should cooperate to f...
by Kwak Sung-sun  |  2018-09-07 16:21
Biopharmaceuticals lead Korea’s drug output growth
Korea’s pharmaceutical output has exceeded 20 trillion won ($17.8 billion) ...
by Lee Hye-seon  |  2018-09-07 13:47
Antihypertensive drug Kanarb tops output among local new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb marked the large...
by Lee Hye-seon  |  2018-09-07 11:08
‘High-value medical devices marketable without sufficient clinical grounds’
The government is seeking to allow companies to sell potentially valuable m...
by Park Gi-taek  |  2018-09-06 15:58
SNUH, Philips to cooperate on developing medical care model
Seoul National University Hospital (SNUH) said Tuesday that it has conclude...
by Lee Han-soo  |  2018-09-06 15:57
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma
The Korean government has approved Ono Pharma Korea and Bristol-Myers Squib...
by Nam Doo-hyun  |  2018-09-06 15:02
Spectrum announces new clinical trial results for Hanmi's lung cancer drug
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Tuesday that it present...
by Lee Han-soo  |  2018-09-06 14:34
Minimal invasive surgery for patients with degenerative vertebral deformity
The Catholic University of Korea, Seoul St. Mary's Hospital has proved ...
by Lee Han-soo  |  2018-09-06 12:47
Antidiabetic combo Steglujan approved in Korea
MSD Korea said it has won approval to sell an antidiabetic combination drug...
by Lee Hye-seon  |  2018-09-06 11:55
Hugel to set up US offshoot
Hugel said Wednesday that it plans to establish a subsidiary in the United ...
by Lee Han-soo  |  2018-09-06 11:55
Seoul decides to reimburse Janssen’s plaque psoriasis treatment
Janssen, a subsidiary of Johnson and Johnson, said Wednesday the Ministry o...
by Lee Han-soo  |  2018-09-05 17:59
Back to Top